Company profile
Akasi Pharma company profile
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions, particularly diabetic peripheral neuropathic pain (DPNP). This condition affects a significant number of diabetics, with a lifetime incidence of about 50%, and is notoriously difficult to treat effectively with existing option
Business identity
- Website
- https://akasipharma.com
- Contact email
- [email protected].
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2025-01-01
Headquarters
- Headquarters
- Copenhagen, Capital Region, Denmark
- Country code
- DK
- Continent
- Europe